Labcorp Holdings (LH) Current Deferred Revenue (2015 - 2026)

Labcorp Holdings has disclosed Current Deferred Revenue across 12 years of filings, most recently posting $387.8 million for Q2 2026.

• In Q2 2026, Current Deferred Revenue fell 2.56% year-over-year to $387.8 million; the TTM figure through Jun 2026 stood at $387.8 million (down 2.56% YoY), while the FY2025 annual figure was $439.1 million, up 11.96% from the prior year.
• Current Deferred Revenue came in at $387.8 million for Q2 2026 at Labcorp Holdings, down from $405.2 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $586.7 million in Q1 2023 to a low of $310.6 million in Q4 2022.
• Average Current Deferred Revenue over 5 years is $424.0 million, with a median of $395.1 million recorded in 2024.
• Year-over-year, Current Deferred Revenue tumbled 44.39% in 2022 and jumped 35.77% in 2023.
• Over 5 years, Current Deferred Revenue stood at $310.6 million in 2022, then jumped by 35.77% to $421.7 million in 2023, then declined by 7.0% to $392.2 million in 2024, then advanced by 11.96% to $439.1 million in 2025, then slipped by 11.68% to $387.8 million in 2026.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $387.8 million in Q2 2026, $405.2 million in Q1 2026, and $439.1 million in Q4 2025.